Learning Level: Intermediate
Time: 0500 – 0630 ET
Session Length: 1.5 hours

The pressure points of the COVID-19 pandemic have been an unprecedented challenge for the pharmaceutical industry and generated a global spotlight on supply resiliency for drug shortage prevention. This webinar has been developed in response to the increasing interest in how best to ensure continuous pharmaceutical supply. Industry and regulatory experts will reflect on the current state of drug shortage prevention, supply resiliency opportunities for all types of pharmaceutical manufacturing (e.g., API, finished product, packaging, bios/small molecule…etc) and share thoughts on how we may do better.

Learning Objectives

  1. Provide the audience with a better understanding of the key opportunities to advance drug shortage prevention.
  2. Hear and explore current thinking on drug shortage prevention from global health authority regulators
  3. Share information on key resources available for improving drug shortage prevention and inspire manufacturers to pursue improvements.

Register Now!



Jesusa Joyce N. Cirunay, RPh
Director IV
Center for Drug Regulation & Research, Food and Drug Administration-Philippines
Lisa Hedman
Senior Advisor, Division of Access To Medicines and Health Products (MHP)
WHO Division of Access To Medicines and Health Products (MHP)
Diane L. Hustead
Executive Director, Regulatory Affairs
Merck & Co., Inc.
Susan Mountain
Regional Supply Chain Lead for South East Asia, Hong Kong & India
Vivien E. Santillan
Regional Director, Asia
Novatek International